These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7091946)

  • 1. Reversible hepatic veno-occlusive disease and 6-thioguanine.
    Krivoy N; Raz R; Carter A; Alroy G
    Ann Intern Med; 1982 Jun; 96(6 Pt 1):788. PubMed ID: 7091946
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic veno-occlusive disease caused by 6-thioguanine.
    Gill RA; Onstad GR; Cardamone JM; Maneval DC; Sumner HW
    Ann Intern Med; 1982 Jan; 96(1):58-60. PubMed ID: 7053705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-thioguanine as a cause of toxic veno-occlusive disease of the liver.
    Satti MB; Weinbren K; Gordon-Smith EC
    J Clin Pathol; 1982 Oct; 35(10):1086-91. PubMed ID: 6957419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peliosis hepatis induced by 6-thioguanine administration.
    Larrey D; Fréneaux E; Berson A; Babany G; Degott C; Valla D; Pessayre D; Benhamou JP
    Gut; 1988 Sep; 29(9):1265-9. PubMed ID: 3198003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases.
    Griner PF; Elbadawi A; Packman CH
    Ann Intern Med; 1976 Nov; 85(5):578-82. PubMed ID: 1068643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of psoriasis with 6-thioguanine and hepatic venoocclusive disease.
    Romagosa R; Kerdel F; Shah N
    J Am Acad Dermatol; 2002 Dec; 47(6):970-2; author reply 972. PubMed ID: 12451396
    [No Abstract]   [Full Text] [Related]  

  • 7. The thiopurine methyltransferase genetic polymorphism is associated with thioguanine-related veno-occlusive disease of the liver in children with acute lymphoblastic leukemia.
    Lennard L; Richards S; Cartwright CS; Mitchell C; Lilleyman JS; Vora A;
    Clin Pharmacol Ther; 2006 Oct; 80(4):375-83. PubMed ID: 17015055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI Patterns in a Case of 6-Thioguanine-Related Hepatic Sinusoidal Obstruction Syndrome.
    Marasco G; Scaioli E; Renzulli M; Colecchia A; Golfieri R; Festi D; Bazzoli F; Digby RJ; Belluzzi A
    Am J Gastroenterol; 2016 Jun; 111(6):767. PubMed ID: 27249976
    [No Abstract]   [Full Text] [Related]  

  • 9. 6-Thioguanine therapy for psoriasis causing toxic hepatic venoocclusive disease.
    Kao NL; Rosenblate HJ
    J Am Acad Dermatol; 1993 Jun; 28(6):1017-8. PubMed ID: 8496447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thioguanine treatment-related sinusoidal obstruction syndrome in 2 children].
    Mao JQ; Zhao FY; Song H; Yang SL; Shen DY; Tang YM
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):788-90. PubMed ID: 24034928
    [No Abstract]   [Full Text] [Related]  

  • 11. Low and adequately dosed 6-thioguanine: not so bad after all.
    de Boer NK; Jharap B; Mulder C; van Bodegraven AA
    Inflamm Bowel Dis; 2008 Aug; 14(8):1166-7. PubMed ID: 18340650
    [No Abstract]   [Full Text] [Related]  

  • 12. 6-Thioguanine-related hepatotoxicity in patients with inflammatory bowel disease: dose or level dependent?
    Derijks LJ; Gilissen LP; de Boer NK; Mulder CJ
    J Hepatol; 2006 Apr; 44(4):821-2. PubMed ID: 16487623
    [No Abstract]   [Full Text] [Related]  

  • 13. 6-Thioguanine-related chronic hepatotoxicity and variceal haemorrhage in children treated for acute lymphoblastic leukaemia--a dual-centre experience.
    Ravikumara M; Hill FG; Wilson DC; Gillett PM; Thomas A; Brown R; Darbyshire PJ; McKiernan PJ
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):535-8. PubMed ID: 16707977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatotoxicity following 6-thioguanine therapy for childhood acute lymphoblastic leukaemia.
    Piel B; Vaidya S; Lancaster D; Taj M; Pritchard-Jones K
    Br J Haematol; 2004 May; 125(3):410-1; author reply 412. PubMed ID: 15086428
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia.
    De Bruyne R; Portmann B; Samyn M; Bansal S; Knisely A; Mieli-Vergani G; Dhawan A
    J Hepatol; 2006 Feb; 44(2):407-10. PubMed ID: 16226335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?
    Gilissen LP; Derijks LJ; Driessen A; Bos LP; Hooymans PM; Stockbrügger RW; Engels LG
    Dig Liver Dis; 2007 Feb; 39(2):156-9. PubMed ID: 17188950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-Thioguanine treatment in inflammatory bowel disease: a critical appraisal by a European 6-TG working party.
    de Boer NK; Reinisch W; Teml A; van Bodegraven AA; Schwab M; Lukas M; Ochsenkühn T; Petritsch W; Knoflach P; Almer S; van der Merwe SW; Herrlinger KR; Seiderer J; Vogelsang H; Mulder CJ;
    Digestion; 2006; 73(1):25-31. PubMed ID: 16493198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Halothane hepatotoxicity and hepatic circulation].
    Hori T; Nagasaka H; Matsumoto N
    Masui; 1988 Mar; 37(3):268-79. PubMed ID: 3294458
    [No Abstract]   [Full Text] [Related]  

  • 19. ECCO consensus: evidence-based use of 6-thioguanine therapy in Crohn's disease?
    de Boer NK; van Asseldonk DP; van Bodegraven A
    J Crohns Colitis; 2010 Oct; 4(4):484-5. PubMed ID: 21122549
    [No Abstract]   [Full Text] [Related]  

  • 20. The early sinusoidal lesion in experimental veno-occlusive disease of the liver.
    McLean EK
    Br J Exp Pathol; 1969 Jun; 50(3):223-9. PubMed ID: 5792896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.